Evidence map›Paper›PMID 40479062›Full record

ReviewScience advances2025

CoREST in pieces: Dismantling the CoREST complex for cancer therapy and beyond.

Houssam Ismail, Jalila Chagraoui, Guy Sauvageau

Abstract readReview
In one paragraph

Review in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Houssam IsmailInstitute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0003-4791-5083
Jalila ChagraouiInstitute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.
Guy SauvageauInstitute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Québec, Canada.ORCID 0000-0002-4333-7266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several landmark studies over the past decade have uncovered a critical role of the CRL3

Indexed as

Co-Repressor ProteinsNeoplasmsAnimalsHumansCo-Repressor Proteins

Identifiers

PMID40479062
PMCPMC12143397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.